Ameritas Investment Partners’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
PVM
NI
Ameritas Investment Partners's HCAT Position: Q2 2026 in Review
Ameritas Investment Partners sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 5,546 shares — an estimated $7.04K sold.
Ameritas Investment Partners first reported a position in HCAT in Q3 2019 and held it in 27 quarters. The position peaked at $195K in Q2 2021. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- Ameritas Investment Partners reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
- Ameritas Investment Partners sold 5,546 Health Catalyst shares in Q2 2026, an estimated $7.04K.
- Ameritas Investment Partners first reported a position in Health Catalyst in Q3 2019 and held it in 27 quarters.
- Ameritas Investment Partners's Health Catalyst position peaked at $195K in Q2 2021.
- 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.